Does Rallies show Form 4 insider transactions for RVTY?

Yes. Rallies tracks RVTY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is RVTY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.

RVTY (Revvity, Inc.) Stock Analysis - Insider Trades

Revvity, Inc. (RVTY) is a publicly traded Healthcare sector company. As of May 20, 2026, RVTY trades at $94.89 with a market cap of $10.65B and a P/E ratio of 46.01. RVTY moved -0.97% today. Year to date, RVTY is -7.11%; over the trailing twelve months it is +1.30%. Its 52-week range spans $81.22 to $129.50. Analyst consensus is buy with an average price target of $104.75. Rallies surfaces RVTY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading RVTY stock inside the company?

Recent RVTY insider activity includes Gonzales Anita sold 80, Victor Miriame sold 1.86K, McMurry-Heath Michelle sold 600, Singh Prahlad R. sold 1.31K, and Singh Prahlad R. sold 12.19K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

RVTY Key Metrics

Key financial metrics for RVTY
Metric	Value
Price	$94.89
Market Cap	$10.65B
P/E Ratio	46.01
EPS	$2.07
Dividend Yield	0.07%
52-Week High	$129.50
52-Week Low	$81.22
Volume	1.05M
Avg Volume	0
Revenue (TTM)	$2.86B
Net Income	$241.20M
Gross Margin	0.00%

Recent RVTY Insider Trades

Gonzales Anita sold 80 (~$7.42K) on Apr 20, 2026.
Victor Miriame sold 1.86K (~$180.86K) on Feb 24, 2026.
McMurry-Heath Michelle sold 600 (~$58.36K) on Feb 23, 2026.
Singh Prahlad R. sold 1.31K (~$129.42K) on Feb 5, 2026.
Singh Prahlad R. sold 12.19K (~$1.21M) on Feb 5, 2026.

Latest RVTY News

Revvity jumps after Q1 EPS beat as investors look past lowered 2026 outlook — May 6, 2026
Revvity jumps as Q1 EPS beats and China immunodiagnostics divestiture unveiled — May 5, 2026
Revvity jumps as Signals BioDesign launch spotlights software growth ahead of earnings — Apr 30, 2026
Revvity slides ahead of May 5 earnings as growth outlook faces scrutiny — Apr 29, 2026
Revvity drops nearly 8% as investors de-risk ahead of May 5 earnings — Apr 23, 2026

RVTY Analyst Consensus

10 analysts cover RVTY: 0 strong buy, 3 buy, 7 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $104.75.

Common questions about RVTY

Who is trading RVTY stock inside the company?: Recent RVTY insider activity includes Gonzales Anita sold 80, Victor Miriame sold 1.86K, McMurry-Heath Michelle sold 600, Singh Prahlad R. sold 1.31K, and Singh Prahlad R. sold 12.19K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for RVTY?: Yes. Rallies tracks RVTY insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is RVTY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for RVTY. It does not provide personalized investment advice.